Department of Gastroenterology and Hepatology, Sestre Milosrdnice University Hospital Center, Zagreb, Croatia; University of Zagreb School of Medicine, Zagreb, Croatia.
Department of Gastroenterology and Hepatology, Sestre Milosrdnice University Hospital Center, Zagreb, Croatia.
Turk J Gastroenterol. 2022 Mar;33(3):190-195. doi: 10.5152/tjg.2022.21050.
Severe acute respiratory syndrome coronavirus 2 pandemic is affecting public health systems and mental health significantly. Patients with inflammatory bowel disease are witnessing vigorous organizational changes in inflammatory bowel disease centers and experiencing all psychosocial effects of the crisis. We conducted a single-center cross-sectional study in order to assess inflammatory bowel disease patients' concerns, behavior, and satisfaction with provided healthcare during severe acute respiratory syndrome coronavirus 2 pandemic.
All inflammatory bowel disease patients treated in our center from April 1 to June 1, 2020, were invited to fulfill an anonymous online questionnaire.
A total of 132 participants have completed the questionnaire, 63.2% were female, 57.9% had Crohn's disease (CD) During the first wave of the pandemic, 74.2% of participants perceived themselves as a high-risk group for acquiring coronavirus disease 2019 only because they suffered from inflammatory bowel disease, and 66.2% thought inflammatory bowel disease medications make them more susceptible to coronavirus disease 2019. This especially concerned patients treated with biologics (B = 2.068, P < .01). Females were more stressed (B = -1.451, P < .01) and concerned (B = -1.488, P < .01) about the pandemic, and they also reported more potential benefits from professional psychological help (B = -2.664, P = .02). Six patients (5.3%) discontinued inflammatory bowel disease therapy on their own initiative. Seventy-eight (68.4%) patients were completely satisfied and 14 (12.3%) were partially satisfied with the quality of healthcare provided in our inflammatory bowel disease center.
Female inflammatory bowel disease patients tend to be more emotionally vulnerable during severe acute respiratory syndrome coronavirus 2 pandemic. Although psychological support should be continuously available to all inflammatory bowel disease patients, female gender may warrant special attention. Providing patients with adequate and early information during pandemic probably leads to better compliance and higher satisfaction.
严重急性呼吸系统综合征冠状病毒 2 大流行对公共卫生系统和心理健康产生了重大影响。炎症性肠病患者正在目睹炎症性肠病中心的积极组织变革，并经历着这场危机带来的所有社会心理影响。我们进行了一项单中心横断面研究，以评估严重急性呼吸系统综合征冠状病毒 2 大流行期间炎症性肠病患者对疾病的担忧、行为以及对所提供医疗保健的满意度。
我们邀请了 2020 年 4 月 1 日至 6 月 1 日在我们中心接受治疗的所有炎症性肠病患者填写匿名在线问卷。
共有 132 名参与者完成了问卷，63.2%为女性，57.9%患有克罗恩病（CD）。在大流行的第一波中，74.2%的参与者认为自己因患有炎症性肠病而属于感染 2019 年冠状病毒病的高风险人群，66.2%的参与者认为炎症性肠病药物使他们更容易感染 2019 年冠状病毒病。这尤其令接受生物制剂治疗的患者感到担忧（B = 2.068，P <.01）。女性对大流行的压力更大（B = -1.451，P <.01），也更担心（B = -1.488，P <.01），她们也报告了从专业心理帮助中获得更多潜在益处（B = -2.664，P =.02）。有 6 名患者（5.3%）自行停止了炎症性肠病治疗。78 名患者（68.4%）对我们炎症性肠病中心提供的医疗质量完全满意，14 名患者（12.3%）部分满意。
在严重急性呼吸系统综合征冠状病毒 2 大流行期间，女性炎症性肠病患者往往更容易情绪脆弱。尽管应持续向所有炎症性肠病患者提供心理支持，但女性患者可能需要特别关注。在大流行期间为患者提供充足和及时的信息可能会导致更好的依从性和更高的满意度。
